The United States has announced the cessation of its HIV funding to South Africa, a decision that threatens to unravel decades of progress in combating the epidemic. The move, confirmed by the US State Department, redirects resources to domestic programmes, leaving a funding gap of approximately $400 million annually. This abrupt withdrawal has prompted global health experts to call on the UK to assume a leadership role in health diplomacy, leveraging its soft power and institutional expertise.
South Africa bears the world's heaviest HIV burden, with 7.8 million people living with the virus. The US President's Emergency Plan for AIDS Relief (PEPFAR) has provided antiretroviral therapy to 2.4 million South Africans, reducing AIDS-related deaths by 60% since its peak in 2005. The funding halt jeopardises these gains, risking a resurgence in transmission and mortality.
‘This is not merely a budgetary decision. It is a geopolitical signal that the US is retreating from its commitments to global health,’ said Dr. Thandi Mbeki, an epidemiologist at the University of Cape Town. ‘The UK must step up, not just as a donor but as a coordinator of international efforts.’
Calls for UK leadership are not without precedent. The UK has contributed £1.2 billion to the Global Fund since 2010 and has a strong track record in HIV research and treatment. However, its aid budget has faced cuts from 0.7% to 0.5% of gross national income. Any expansion of its role would require reallocation of resources and political will.
The timing is critical. The World Health Organization reports that HIV incidence in South Africa has plateaued, with 230,000 new infections in 2023. Disruption to treatment could accelerate drug resistance, a threat that transcends borders. ‘HIV does not respect national budgets,’ warned Dr. Helena Vance, Science and Climate Correspondent. ‘A funding gap is not a vacuum. It becomes a vector for disease spread.’
Advocates urge the UK to convene an emergency summit with G20 nations, the African Union, and private foundations to fill the void. The Wellcome Trust and the Bill & Melinda Gates Foundation have expressed conditional interest but insist on government leadership.
The US decision, framed as ‘domestic prioritisation,’ mirrors a broader trend of declining global health investment. The pandemic has shifted focus, but HIV remains a leading cause of death among women of reproductive age in sub-Saharan Africa. ‘We are at a fork in the road,’ said Dr. Mbeki. ‘One path leads to a resurgence of AIDS. The other requires a new compact for global health equity.’
As the UK deliberates, the clock is ticking. South Africa’s health system, already strained by tuberculosis and non-communicable diseases, cannot absorb the shock without assistance. The next month will determine whether the world learns from history or repeats its failures.
